Dr. Christopher M. Sinko is Senior Vice President, Pharmaceutical Development within the Research and Development Division of Bristol-Myers Squibb Company in Princeton, New Jersey. His current responsibilities include the disciplines for drug development and registration and the successful transfer of products and processes into commercial manufacturing. This role spans chemical development, analytical development, formulation development (small molecules and biologics), clinical supplies manufacturing and distribution. Prior to his current role he was Vice President, Drug Product Science and Technology at BMS. From 1991 to 2008, he held scientific and leadership roles at Pfizer Inc in Groton Connecticut including Executive Director, Global Materials Science as well as leading the Oral Products Center of Emphasis. Previously, he has held leadership roles in Analytical R&D, Solid Dosage Forms R&D, Clinical Manufacturing Operations and Technology Transfer at Pfizer. In 1989 he started his industrial career as a scientist at the Upjohn Company. Dr. Sinko received his B.S. in Chemical Engineering with a concentration in Materials Engineering from Rutgers University (1984), continued his education at the University of Michigan under the direction of Professor Gordon L. Amidon and received an M.S. and Ph.D. in Pharmaceutics in 1986 and in 1989, respectively. He has published and presented in the following areas of research: solid state relaxation phenomena, water transport, dissolution, mechanical characterization, percolation theory application, powder flow, powder physics and mechanics, finite element analysis, powder lubrication and Quality by Design.